Stocks to Watch: Nvidia Partners with SK Hynix, Marvell and Flex Join S&P 500
Several companies are experiencing notable stock movements due to partnerships and index changes, which could influence investor sentiment and market dynamics.
Roche
Preço: 51.65Empresa e modelo de negócios
Roche is a global healthcare company specializing in pharmaceuticals and diagnostics. Its core products include prescription medications, particularly in oncology, immunology, and neuroscience, as well as diagnostic tools for various diseases. Major business segments are Pharmaceuticals and Diagnostics, with primary revenue sources stemming from drug sales and diagnostic testing services. The company is known for its strong research and development capabilities, contributing to its innovative product pipeline.
Perfil de investimento
Roche's investment profile is characterized by a balanced approach, appealing to investors seeking both growth and dividends. The company offers a stable dividend yield, making it attractive for income-focused investors, while its strong revenue growth indicates potential for capital appreciation. This combination positions Roche as suitable for those looking for a reliable investment with moderate risk.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 2.73 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 90.4% ↑
- Volatilidade 20d
- 1.8% estável
- Dividend yield
- 3.1% moderado última data ex-dividendo: 2026-03-13
Dados FMP / FinFeed atualizados:
2026-06-11
Rec.: Comprar
Potencial: 67
Risco: 35
Atualizado: 2026-06-13 02:58
Como a recomendação funciona
Por que a IA pensa assim:
Strong fundamentals and solid dividend yield support growth.
Acompanhar no portfólio
Gráfico de preço
Recomendação da IA
Previsão do analista
Evento de calendário
Sinal positivo
Sinal negativo
Neutro / atualização
Manter / informativo
B My buy
S My sell
Mudanças na recomendação da IA
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-05 02:47 | Vender | Comprar | Strong revenue growth, but mixed momentum signals. |
| 2026-06-03 02:51 | Manter | Vender | Weak momentum and high risk limit upside potential. |
| 2026-06-01 02:49 | Comprar | Manter | Solid fundamentals, but mixed momentum signals present uncertainty. |
Previsões de analistas
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2025-12-10 11:17 | HSBC | Preço-alvo elevado | 50 → 57 | 48.66 |
| 2025-10-02 09:07 | HSBC | Rating elevado | — → 50 | 44.83 |